Plus therapeutics, inc. receives notification of deficiency from nasdaq related to delayed filing of quarterly report on form 10-q

Houston, may 23, 2025 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”) today announced it received a delinquency notification letter from nasdaq on may 21, 2025, which indicated that the company was not in compliance with nasdaq listing rule 5250(c)(1) as a result of the delayed filing of the company's quarterly report on form 10-q for the period ended march 31, 2025 (the “quarterly report”). the nasdaq listing rule requires listed companies to timely file all required periodic financial reports with the u.s. securities and exchange commission (the “sec”).
PSTV Ratings Summary
PSTV Quant Ranking